These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6989592)

  • 1. [Intensified therapy of newly detected maturity onset diabetes].
    Pissarek D; Panzram G; Lundershausen R; Adolph W; Senf L
    Endokrinologie; 1980 Jan; 75(1):105-15. PubMed ID: 6989592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenetic relationships between obesity and maturity-onset diabetes].
    Spanár E; Uhrín P; Levcík A; Záhradný V
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 170-1. PubMed ID: 930174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
    Lisch HJ; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1980 Apr; 92(8):266-9. PubMed ID: 6996339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma insulin studies in two hundred patients with diabetes mellitus.
    McKiddie MT; Buchanan KD; Hunter IA
    Q J Med; 1969 Oct; 38(152):445-65. PubMed ID: 5355537
    [No Abstract]   [Full Text] [Related]  

  • 5. [The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
    Vogelberg KH; Cicmir I; Heggen ME
    Arzneimittelforschung; 1980; 30(4):683-5. PubMed ID: 7190412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of the body weight in 2261 maturity-onset diabetics under conditions of ambulatory care].
    Möricke R; Hunecke I; Ries W; Oehler S; Reichenbach O
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 167-70. PubMed ID: 930173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results in diabetic therapy with Silubin retard. 3].
    Kopp H
    Med Klin; 1971 Feb; 66(7):246-7. PubMed ID: 5552720
    [No Abstract]   [Full Text] [Related]  

  • 8. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J; Soszyński P
    Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose disturbances and regulation with glibenclamide in thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():871-8. PubMed ID: 10091160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term effects of weight reduction on body weight and metabolic parameters in adipose non-diabetics and adipose maturity-onset diabetics].
    Schneider H; Zschornak M; Neumann I; Haller H
    Z Gesamte Inn Med; 1981 Apr; 36(7):301-4. PubMed ID: 7281831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of diabetes therapy with Silubin retard].
    Kopp H
    Med Klin; 1966 Apr; 61(15):592-6. PubMed ID: 4869026
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of long-term biguanide therapy as a preventive measure in protodiabetes].
    Neumann VI; Michaelis D; Schulz B; Wulfert P; Heinke P
    Endokrinologie; 1975 Feb; 64(3):290-8. PubMed ID: 1227826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal dlabetes and chemical diabetes. Course in young subjects with normal weight (author's transl)].
    Schrub JC; Courtois H; Vuillermet P
    Nouv Presse Med; 1978 Jun; 7(24):2145-7. PubMed ID: 683861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study.
    Aas AM; Bergstad I; Thorsby PM; Johannesen O; Solberg M; Birkeland KI
    Diabet Med; 2005 Mar; 22(3):316-22. PubMed ID: 15717881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose metabolism in hyperglycaemic rats.
    Pari L; Saravanan R
    Diabetes Obes Metab; 2004 Jul; 6(4):286-92. PubMed ID: 15171753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.